Login / Signup

Risk and timing of isotretinoin-related laboratory disturbances: a population-based study.

Shirin EmtenaniMariam AbdelghaffarRalf J LudwigEnno SchmidtKhalaf Kridin
Published in: International journal of dermatology (2024)
Isotretinoin is associated with a clinically marginal increased risk of severe hypertriglyceridemia and hypertransaminasemia. Routine blood testing should be performed 1-3 months after commencing therapy.
Keyphrases
  • clinical practice
  • early onset
  • mesenchymal stem cells
  • cell therapy